Most recently, it's been identified that conolidine and the above derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in similar places as classical opioid receptors, it binds to some wide array of endogenous opioids. Unlike most opioid receptors, this receptor acts like a scavenger and won't activate a second messenger s